Mazemal CR 400 mg Tablet

-Active Ingredient: Carpamazepine 400 mg controlled release form.

-Pack: 10t. 1st.

-Indications:

  1. Widely accepted as a drug of first choice for epileptic people.
  2. Recommended by international guidelines in management of diabetic neuropathy.
  3. A gold standard against for trigeminal neuralgia which other drugs have been compared in clinical trials.